Showing results (741-750 of 832) with videos related to
Sort By:
Pageof 84
JAMA Internal Medicine|February 26, 2024
COVID-19-Associated Acute Kidney Injury and Longitudinal Kidney OutcomesAbinet M Aklilu, Sanchit Kumar, James Nugent, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 21, 2010
An MHC-defined primate model reveals significant rejection of bone marrow after mixed chimerism induction despite full MHC matchingC P Larsen, A Page, K H Linzie, et al.The Journal of Rheumatology|August 1, 1996
V beta 17 T cell receptor peptide vaccination in rheumatoid arthritis: results of phase I dose escalation studyL W Moreland, L W Heck, W J Koopman, et al.Circulation. Heart Failure|March 26, 2020
Testing for Coronary Artery Disease in Older Patients With New-Onset Heart Failure: Findings From Get With The Guidelines-Heart FailureKyle D O'Connor, Todd Brophy, Gregg C Fonarow, et al.Cell|September 11, 2025
Microglia-astrocyte crosstalk regulates synapse remodeling via Wnt signalingTravis E Faust, Yi-Han Lee, Ciara D O'Connor, et al.Frontiers in Nutrition|February 25, 2022
Interpreting Clinical Trials With Omega-3 Supplements in the Context of Ancestry and FADS Genetic VariationFloyd H Chilton, Ani Manichaikul, Chaojie Yang, et al.Journal of Medicinal Chemistry|February 21, 2018
Development of (6 R)-2-Nitro-6-[4-(trifluoromethoxy)phenoxy]-6,7-dihydro-5 H-imidazo[2,1- b][1,3]oxazine (DNDI-8219): A New Lead for Visceral LeishmaniasisAndrew M Thompson, Patrick D O'Connor, Andrew J Marshall, et al.Journal of Medicinal Chemistry|May 2, 2017
7-Substituted 2-Nitro-5,6-dihydroimidazo[2,1-b][1,3]oxazines: Novel Antitubercular Agents Lead to a New Preclinical Candidate for Visceral LeishmaniasisAndrew M Thompson, Patrick D O'Connor, Andrew J Marshall, et al.Proceedings of the National Academy of Sciences of the United States of America|April 16, 2020
Evolutionary history of modern SamoansDaniel N Harris, Michael D Kessler, Amol C Shetty, et al.Molecular Cancer Therapeutics|May 8, 2012
Engineering and therapeutic application of single-chain bivalent TGF-β family trapsJohn C Zwaagstra, Traian Sulea, Jason Baardsnes, et al.Pageof 84